Heart Failure Monitoring Systems Market

Heart Failure Monitoring Systems Market Outlook (2024 to 2034)

The global heart failure monitoring systems market was valued at US$ 13,379.4 million in 2023 and has been forecasted to expand at a noteworthy CAGR of 5.7% to end up at US$ 24,612.2 million by 2034.

The heart failure monitoring system (HFMS) refers to a device or system used to monitor the health of people bearing heart failure. HFMS can be used for monitoring heart function in many ways such as heart rate, blood pressure, and blood oxygen.

There are several types of monitoring systems for the management of heart failure i.e. implantable devices, wearable devices, and mobile devices. HFMS helps patients with heart failure and healthcare professionals to better analyze a patient's health parameters.

The market is set to boost with the increase in the aging population, increase in cardiovascular diseases, and rise in technological advancement. Development in technological innovations, non-invasive devices, accuracy, and small, and easily efficient monitoring devices are driving the market growth.

For instance, the use of homecare patient monitoring devices has been driving the industry with products such as wearable devices as well as implantable devices which are more efficiently and easily used by the aging population.

Thus, heart monitoring systems are poised to grow significantly at 5.7% CAGR in the mentioned forecast period.

Report Attributes	Details
Heart Failure Monitoring Systems Market Size (2023A)	US$ 13,379.4 Million
Estimated Market Value (2024E)	US$ 14,079.6 Million
Forecasted Market Value (2034F)	US$ 24,612.2 Million
Global Market Growth Rate (2024-2034)	5.7% CAGR
East Asia Market Share (2024)	21.6%
China Market Growth Rate (2024-2034)	8.4% CAGR
Key Companies Profiled	Abbott Laboratories, Inc.; Boston Scientific Corporation; Medtronic Plc.; General Electric (GE HealthCare); Koninklijke Philips N.V.; Avertix Medical Inc.; Endotronix, Inc.; Uscom Ltd.; Other Prominent Players.

Historic Analysis (2019 to 2023) Vs Future (2024 to 2034) Pathway Analysis for the Heart Failure Monitoring Systems Market

In 2019, due to the rising investment in research and development by private and government entities, the market grew steadily. This investment further gained traction in wearable devices and remote patient monitoring.

In the Historical Year, the COVID-19 pandemic had a positive impact on the healthcare industry which shifted focus to telemedicine and remote patient monitoring. The adoption of monitoring devices has become crucial in the healthcare sector.

• Short Term (2024 to 2027): The Integration of AI and Machine learning will show trajectory growth for the heart monitoring systems market. AI in the future will support predictive analysis and monitor patients in real-time. This will further boost disease management in a particular course.
• Medium Term (2027 to 2030): As and how technology advances and adoption rises, the growth in underdeveloped and developed countries will see significant growth. Further, the use of AI, machine learning, and electronic health records (EHR) will enhance care and efficiency in the healthcare industry.
• Long Term (2030 to 2034): By 2034 the market will reach to maturation phase of the product life cycle with involvement in personalized medicines/treatment. With the help of ML and AI, healthcare providers will help build more personalized treatment.

On the back of the aforementioned facts, the heart monitoring system market is anticipated to grow at a CAGR of 5.7% during the forecast period from 2024 to 2034, According to the Fact.MR, a market research and competitive intelligence provider.

Market Dynamics

What are the Factors Propelling Global Sales of Heart Failure Monitoring Systems?

People are using digital health solutions worldwide to monitor various things, from sleep patterns to blood sugar levels. Digital health has evolved from a service taken up by those pursuing health and fitness to the masses, with a high number of participants in health and wellness tracking.

According to the industry organization GFU Consumer & Home Electronics, among a survey of 4,000 consumers in Germany, Great Britain, the United States, and China, 44% of Germans use at least four health-related metrics (e.g., heart rate, blood sugar, fitness values) from smartwatches or apps to track their health and activities. In the United States, 60% of the population tracks the same data, and in China, 67% of consumers do. The survey “Heartbeat of Progress” was conducted by the industry organization gfu Consumer & Home Electronics and the strategy team at Oliver Wyman.

The digital health sector is also attractive to the capital markets, contributing to market growth. The start-up community has experienced a tenfold increase in funding, compared to levels seen before 2015. This growth has produced many milestones, such as the development of non-invasive glucose measurement. Over 80% of consumers already find these developments to be inspiring. Thus, the rising demand for tech in the medical field is driving the heart failure monitoring systems market.

“Increasing Cardiovascular Disorders”

Cardiovascular diseases are a group of diseases affecting blood vessels and heart. They are the leading causes of death globally as per WHO. Cardiovascular takes an estimated millions of lives for instance, WHO in their recent article stated that the cardiovascular death count will be around 17.9 million by 2024. These diseases progress at a slower pace due to factors such as a sedentary lifestyle, smoking, physical inactivity, and age.

Historically, in 2000 fourteen million people lost their lives while in 2019, around 18 million people lost their lives to major cardiovascular diseases. These factors mark the importance of preventive and diagnostics devices in the healthcare field. Cardiovascular diseases are significantly impacting the market growth in the forecast period.

The rise in clinical trials has also been taking a hike. As more industry manufacturers gained interest in developing innovative devices that will show significant returns is driving the market growth.

• For instance, In October 2023, the FDA granted Endotronix an experimental device exemption (IDE) so that the company's Cordella Sensor-which will be the subject of the PROACTIVE-HF 2 study-may be used for hemodynamic monitoring in a new clinical trial.

“Rising Healthcare Infrastructure”

As the world is growing with amazing facilities and services, the spending on health and services has also increased. The adoption of technologically advanced devices and or wearables trend is usually seen in developed countries as the adoption of advanced systems and devices and their availability is driving the market growth in the future.

For instance, as per Centers for Medicare & Medicaid Services (CMS) 2023, Average NHE growth during 2023 to 2032 (5.6 percent) is projected to exceed average GDP growth during the same period (4.3 percent), which will result in an increase in the health spending share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. NHE spending is expected to have grown 7.5 percent in 2023, outpacing GDP growth of 6.1 percent.

Over the 2027 to 32 period, personal health care price inflation and growing use of health care goods and services are key drivers of projected health spending growing faster than the rest of the economy. This will further enhance and boost the market.

What are the Challenges Encountered by Manufacturers of Heart Monitoring System?

“High Cost of Advanced Monitoring Systems”

Advanced patient-monitoring cardiac devices come with a price tag and not everyone can afford it. For instance, The price range of implantable cardiac devices ranges from $10,000 to $20,000. This high cost of devices is inaccessible by a large portion of the population like low-income areas and high-income areas. There are possibilities based on the insurance plan and coverage that not all the cost of the devices is covered under the claim. Many patients may have to pay out-of-pocket money.

Further, many public and private healthcare service facilities may not be able to incorporate advanced systems in the space, which causes slow adoption of the devices in certain geographies hampering the heart failure monitoring systems market growth.

Country-wise Insights

Why is the Adoption of Heart Failure Monitoring Systems High in the United States?

“Advanced Healthcare Facilities”

The market in the United States is estimated at US$ 4,366.0 million in 2024 and is projected to expand at a CAGR of 5.9% through 2034. This market is projected to generate a US$ 7,876.3 million absolute opportunity for the year 2024.

The U.S. serves as the leader in healthcare infrastructure, and services, and has major healthcare facilities in the world. These healthcare facilities are highly equipped with technologically advanced systems and devices which drives the market growth in the U.S. market.

Why is China a Lucrative Market for Robot Cell Manufacturers?

“Rising Ageing Population”

The China market is growing at a CAGR of 8.4% in 2024 to 2034. China has an ever-growing population. The United Nations recently in their article said that there will be around 366 million old people by 2050. This figure seems to be higher as compared to the U.S. population. As the quality of life and expectancy increases the demand for health products will also rise, boosting the china market.

Category-wise Insights

How is General Heart Function Monitors Impacting the Global Market?

“Rising Incidence of Cardiovascular Diseases and Ailments Demands Heart Monitoring”

Demand for general heart function monitors is projected to increase at a CAGR of 5.0% from 2024 to 2034. The need to pre-diagnose the ailments before it's too late marks the growth of the market. These monitors help healthcare physicians change the disease treatment course and action plan. This further helps in improving the quality of life of the patient, eventually driving the demand the supply of the heart monitoring systems market.

Why do Hospitals Account for Extensive Use of Heart Failure Monitoring Systems?

“Heart Failure Monitoring Systems Mitigating Risk of Unannounced Death”

Hospitals are estimated to account for 63.0% share of the market in 2024, and the segment is projected to reach a market valuation of US$ 15,089.4 million by 2034-end. Hospitals have a constant flow of patients dealing with many symptoms, the day-to-day check-ups, out-patient and in-patient count of number is always higher in the hospitals. The availability of skilled professionals and medical staff will drive the market growth in the next 10 years.

How Does Wireless Technology Shows Better Efficiency Than Wired Technology?

Wireless technology is said to be easy, portable, and cost-friendly, which has caused a rise in adoption of the portable devices. The shift towards wireless from wired technology has become a trend globally. Wireless technology holds 35.5% market share in 2024. This shows lucrative opportunities for wireless technology to grow at a CAGR of 6.3%.

Competitive Landscape

Key players in the heart failure monitoring systems industry are Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic Plc., General Electric (GE HealthCare), Koninklijke Philips N.V., Avertix Medical Inc., Endotronix, Inc., Uscom Ltd.

Companies devote a significant portion of their revenue to R&D to resolve problems and offer creative solutions to draw in new customers and stay competitive. Companies are developing customized offerings for issues that meet industry-specific needs to compete with other players.

• In September 2023, Philips Introduced the New VitalSigns RPM Solution for Heart Failure Patients.
• In July 2021, Avertix announced the introduction of its flagship product, The Guardian device, in the United States and its first commercial installation. The Guardian was being used for the first time after receiving FDA approval recently
• In October 2023, the FDA granted Endotronix an experimental device exemption (IDE) so that the company's Cordella Sensor-which will be the subject of the PROACTIVE-HF 2 study-may be used for hemodynamic monitoring in a new clinical trial.

Fact.MR has provided detailed information about the price points of key manufacturers of heart monitoring systems positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of Heart Failure Monitoring Systems Industry Research

• By Product Type :

  • Systems
    • Doppler Hemodynamics Monitors
    • Implantable Hemodynamic Monitors (IHM)
    • Implantable Pulmonary Artery Monitoring Devices
    • Intrathoracic Impedance Monitors
    • General HF Monitors
  • Data Management Software

• By Technology :

  • Wired
  • Wireless

• By End User :

  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Hospitals

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa